07:54:39 EDT Fri 17 May 2024
Enter Symbol
or Name
USA
CA



Salona Global Medical Device Corp
Symbol SGMD
Shares Issued 56,991,591
Close 2023-12-18 C$ 0.19
Market Cap C$ 10,828,402
Recent Sedar Documents

Salona Global to release Biodex step trainer

2023-12-18 10:58 ET - News Release

Mr. Mike Seckler reports

SALONA GLOBAL ANOUNCES THE DEBUT OF THE BIODEX REACTIVE STEP TRAINER, A REVOLUTIONARY BALANCE TRAINING SYSTEM TO REDUCE FALLS; COMMENCES AI ENABLED SOFTWARE COMPONENT

Salona Global Medical Device Corp. has debuted the Biodex reactive step trainer: a revolutionary medical device that combines Biodex Rehab's industry-leading gait trainer platform with a clinically proven perturbation training system.

There is a critical need for a pro-active approach to fall prevention as the world's population is aging. One in three people over the age of 65 experience at least one fall each year and those falls are the leading cause of fatal and non-fatal injuries in older adults. The RST can help by retraining the neuromuscular system to respond when a person becomes off balance, with the aim of creating muscle memory when recovering from a trip or slip in a controlled environment.

The company plans to launch the product in the United States at the American Physical Therapy Association Combined Sections Meeting in Boston Feb. 15 to 17, 2024.

Available for shipment to customers globally in 2024, the RST medical device further extends the Biodex institutional grade technology and intellectual property to the 48,000-plus physical therapy rehabilitation centres and the approximately 30,600-plus independent living communities in the United States alone.

Additionally, the company is engaging Limmi, a health care artificial intelligence platform company, to develop predictive capabilities for the RST using machine learning from data collected by the device for each individual patient.

"After a record revenue quarter generating a profit, we have debuted another exciting product that has the potential to increase revenue at Biodex," said Mike Seckler, chief executive officer. "Along with the portable Spacetek Knee product we debuted last month, we envision the RST being a staple product for clinics globally. We have two new products that expand our market and that is setting up for a fantastic year in 2024."

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.